The role of self-efficacy in predicting treatment adherence in youth with cystic fibrosis by Szabo, Margo M.
Graduate Theses, Dissertations, and Problem Reports 
2014 
The role of self-efficacy in predicting treatment adherence in 
youth with cystic fibrosis 
Margo M. Szabo 
Follow this and additional works at: https://researchrepository.wvu.edu/etd 
Recommended Citation 
Szabo, Margo M., "The role of self-efficacy in predicting treatment adherence in youth with cystic fibrosis" 
(2014). Graduate Theses, Dissertations, and Problem Reports. 7351. 
https://researchrepository.wvu.edu/etd/7351 
This Thesis is protected by copyright and/or related rights. It has been brought to you by the The Research 
Repository @ WVU with permission from the rights-holder(s). You are free to use this Thesis in any way that is 
permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain 
permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license 
in the record and/ or on the work itself. This Thesis has been accepted for inclusion in WVU Graduate Theses, 
Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. 
For more information, please contact researchrepository@mail.wvu.edu. 
   
 
 
The Role of Self-Efficacy in Predicting Treatment Adherence  
in Youth with Cystic Fibrosis 
by 
Margo M. Szabo, B.S. 
Thesis submitted to  
The Eberly College of Arts and Sciences 
at West Virginia University 
in partial fulfillment of the requirements 
for the degree of 





Christina L. Duncan, Ph.D., Committee Chairperson 
Elisa Krackow, Ph.D. 
Amy Gentzler, Ph.D. 
 
Psychology Department 
Morgantown, West Virginia 
2014 
 
Keywords: cystic fibrosis, pediatric, treatment adherence 
Copyright 2014 Margo M. Szabo 
All rights reserved
INFORMATION TO ALL USERS
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript
and there are missing pages, these will be noted.  Also,  if material had to be removed, 
a note will indicate the deletion.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against
unauthorized copying under Title 17, United States Code
ProQuest LLC.
789 East Eisenhower Parkway
P.O. Box 1346
Ann Arbor,  MI 48106 - 1346
UMI  1554873
Published by ProQuest LLC (2014).  Copyright in the Dissertation held by the Author.
UMI Number:  1554873
   
 
Abstract 
The Role of Self-Efficacy in Predicting Treatment Adherence  
in Youth with Cystic Fibrosis 
by Margo M. Szabo, B.S. 
Adolescents with cystic fibrosis (CF) demonstrate relatively poor treatment adherence in 
comparison to other age groups, which can lead to adverse health outcomes. Though previous 
research has examined various factors associated with treatment adherence in pediatric CF 
samples, no studies to date have explored the interrelations among self-efficacy, parental style, 
level of responsibility for CF care, and treatment adherence in this population. Therefore, the 
purpose of this study was to examine the role of self-efficacy, parental style, and level of 
responsibility for CF care in predicting treatment adherence in adolescents with CF. A sample of 
59 adolescents with CF (M age =15.1; 56% male) and their primary caregivers were recruited from 
three pediatric CF centers across the United States. Results indicated that parental style did not 
moderate the association between youth self-efficacy and treatment adherence. In addition, neither 
youth- nor parent-reported division of responsibility for disease management mediated the 
association between self-efficacy and treatment adherence. However, greater youth self-efficacy 
was significantly associated with youth taking on more responsibility for their disease 
management. Findings of the current study suggest promoting self-efficacy during adolescence 
may increase youth responsibility for their disease management and prepare these youth for the 
transition from pediatric to adult healthcare.  
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The Role of Self-Efficacy in Predicting Treatment Adherence  
in Youth with Cystic Fibrosis 
Cystic fibrosis (CF) is one of the most common life-threatening genetic diseases of the 
Caucasian population and disrupts the function of several vital body organs, including the lungs 
and pancreas. More specifically, approximately 30,000 individuals in the United States are 
currently living with CF (Cystic Fibrosis Foundation, 2011). In addition, CF affects approximately 
1 in 3,500 non-Hispanic, Caucasian children, 1 in 4,000-10,000 Hispanic children, and 1 in 15,000-
20,000 African-American children (Quittner, Barker, Marciel, & Grimley, 2009). CF is caused by 
a mutation of the CF gene, which in turn causes dysfunction of CF transmembrane conductance 
regulator (CFTR) protein (Colin & Wohl, 1994). The dysfunction of the CFTR protein disrupts the 
flow of water through the chloride channel of cells and leads to the secretion of a sticky mucus that 
accumulates in many of the body’s organs (Colin & Wohl, 1994).  
As mucus accumulates in the body, several vital organs are damaged and individuals with 
CF experience disease-related complications. Of these complications, pulmonary infections are the 
major cause of death (Strausbaugh & Davis, 2007). In addition to pulmonary infections, 
gastrointestinal complications and CF-related diabetes are other common manifestations of the 
disease (Strausbaugh & Davis, 2007). Therefore, patients with CF must follow a complex 
treatment regimen to stay healthy, which includes performing daily airway clearance medication 
and techniques (e.g., bronchodilators, inhaled dornase alpha, nebulized hypertonic saline, and chest 
physiotherapy), taking inhaled or oral antibiotics, taking pancreatic enzymes with meals and 
snacks, and eating a daily diet high in calories and fat (Quittner et al., 2009). Due to the complexity 
of this regimen, patients with CF often have difficulty adhering to their treatments. Because poor 






Desmond, Schwenk, Thomas, Beaudry, & Coates, 1983), treatment adherence is a major concern 
among individuals with CF.  
Treatment adherence has been traditionally defined as the extent to which patients comply 
with a treatment plan that is recommended by a healthcare professional (Rapoff, 1999). However, 
there is debate surrounding this definition due to individualized treatment plans for patients with 
the same disease and multiple methods of assessment, which lead to inconsistent rates of adherence 
(Quittner et al., 2009). For example, using a sample of 37 children with CF (ages 6 to 13), Modi 
and colleagues (2006) reported widely different adherence rates depending on the assessment 
method. Rates of adherence for pancreatic enzyme therapy ranged from 27% using daily phone 
diary data to 90% using child self-report data. These authors also found similar patterns of 
adherence when comparing multiple methods for airway clearance techniques, nebulized 
medications, and multivitamins. Overall, objective measures of adherence, such as phone diaries, 
pharmacy refill data, and electronic monitoring, produced significantly lower rates of adherence 
than parent reports, which suggest self-report measures may be inaccurate and emphasize the 
importance of examining adherence through multiple methods (Modi et al., 2006).  
In addition to different assessment methods, rates of adherence among individuals with CF 
differ by age. Czjkowski and Koocher (1986; 1987) reported that 35% of their sample of 40 
adolescent and young adult inpatients with CF (ages 13 to 23) were non-compliant when 
examining physician-reports of adherence, with the oldest patients being the most likely to be non-
compliant. Other studies also have demonstrated a higher rate of non-adherence among older 
children and adolescents with CF, as assessed by self-, parent-, and physician-reports of adherence 






& Hsu, 1998). These findings suggest that children become less adherent to their treatments as they 
age. Conversely, a study by Ziadni and colleagues (2006) demonstrated mixed results regarding 
age-related patterns of adherence to multivitamins (assessed by electronic monitoring) and dornase 
alpha (assessed through collection of empty medication vials). These authors reported that children 
younger than 12 years old exhibited a mean adherence rate of 70.5% for multivitamins, while 
adolescents older than 12 years old demonstrated a mean lower mean adherence rate of 56.7% 
(Ziadni, Streetman, Streetman, & Nasr, 2006). In this same study, adolescents reported being more 
adherent to dornase alfa than children younger than 12 years (70% versus 62.9%). The authors 
reasoned adolescents might have a higher adherence rate of dornase alfa than younger children 
because the adolescents experienced more severe lung disease and the effects of this medication on 
thinning mucus may be perceived as more important for them than for the younger children with 
milder lung disease.  
Although there is evidence that adolescents with CF generally become less adherent to 
treatment as they age, these age-related patterns do not appear to persist into adulthood as studies 
have found moderate to high rates of adherence among adults with CF. For example, White and 
colleagues (2007) stated that 70.2% of their sample of 57 adults with CF reported good adherence 
to their daily chest physiotherapy and 91.2% reported good adherence to their exercise regimen 
when physically well. Burrows and colleagues (2007) also reported 70% of their sample of 42 
adults exhibited good or moderate adherence to dornase alfa when examining pharmacy refill data. 
Taken together, this evidence suggests that treatment adherence rates for adolescents are relatively 
poor in comparison to other age groups of patients with CF. However, these findings should be 






studies assessing age-related patterns of non-adherence in patients with CF are based on self- or 
other-report data. 
Due to advances in treatment, patients with CF are now living into adulthood and require 
age-appropriate care (Dugueperoux et al., 2008). In fact, the median age of survival of patients 
with CF was reported to be 38.3 years in 2010, which is an increase from 27 years in 1986 (Cystic 
Fibrosis Foundation, 2011). Therefore, adolescents must prepare to take responsibility for their 
disease management (i.e., taking their medications, refilling their medications, calling their 
physician when ill) and to transition to adult healthcare, which may leave them vulnerable to poor 
adherence due to less family involvement in their care. Transition has been defined as the process 
of an adolescent or young adult transferring his or her medical care from a pediatric healthcare 
setting to an adult healthcare setting (Tuchman, Schwartz, Sawicki, & Britto, 2010). The median 
age for transition of an adolescent with CF is approximately 19 years old (McLaughlin, Diener-
West, Indurkhya, Rubin, Heckmann, & Boyle, 2008). However, because transition typically is not 
discussed before age 17, adolescents have inadequate time to develop necessary skills to manage 
their CF effectively (McLaughlin et al., 2008).  
Additionally, a major area of parental concern regarding their child’s transition is the 
child’s ability to independently care for his or her CF (Boyle, Farukhi, & Nosky, 2001). Pre-
transition adolescents and post-transition young adults also reported that making their own 
decisions about their CF treatment and being responsible for completing their treatments were 
important skills for a successful transition (Westwood, Henley, & Willcox, 1999). It is possible 
that adolescents who lack appropriate skills to care independently for their disease may be at risk 






of adolescents with various chronic diseases revealed a significant reduction in treatment 
adherence during the time period surrounding transition (Pai & Ostendorf, 2011). Moreover, 
factors related to non-adherence among youth with CF may vary by developmental phase. 
Therefore, it is important to monitor treatment adherence and explore the factors related to 
adherence of adolescents with CF who are preparing for transition.  
Factors Related to Treatment Adherence 
Overall, poor rates of treatment adherence among adolescents with CF have generated 
interest in understanding psychosocial factors that may promote adherence behaviors. As a result, 
numerous studies have examined the associations among various psychosocial factors and 
treatment adherence. However, few studies have examined the roles of self-efficacy, parental style, 
and level of responsibility for CF care and the interrelations among these variables in predicting 
treatment adherence of adolescents with CF. Because previous research has explored the 
association of these variables with treatment adherence using other pediatric chronic illness 
samples, it is possible that these factors are related to treatment adherence in adolescents with CF. 
Furthermore, it makes intuitive sense to select these variables as they seem related to the concept of 
healthcare transition and may be relevant when preparing adolescents with CF to successfully 
transition to adult-oriented care. 
Self-efficacy 
Perceived self-efficacy, an essential component of Bandura’s social cognitive theory 
(1977), is defined as “people's beliefs about their capabilities to produce designated levels of 
performance that exercise influence over events that affect their lives” (Bandura, 1994). More 






believe they can successfully perform tasks necessary to accomplish their goals. Individuals with 
high self-efficacy also are more likely to view difficult situations as challenges rather than threats, 
remain dedicated to accomplishing their goals, and regain their sense of self-efficacy following 
failed tasks (Bandura, 1977). Children and adolescents who report greater self-efficacy tend to 
have better psychosocial functioning across a number of developmental domains, including greater 
academic achievement (Bandura, Barbaranelli, Caprara, & Pastorelli, 1996), more positive self-
image (Bacchini & Magliulo, 2003), and better family functioning (Caprara, Pastorelli, Regalia, 
Scabini, & Bandura, 2005). When it is examined in chronic illness populations, self-efficacy 
denotes the patient’s confidence in his or her abilities to execute tasks and behaviors necessary to 
manage his or her disease (Zebracki & Drotar, 2004). Patients who believe in their abilities to 
perform disease management tasks may be more likely to engage in these tasks and adhere to their 
treatment regimens (Holman & Lorig, 1992). Consequently, it is important to examine the 
association between self-efficacy and treatment adherence in adolescents with CF. 
The association of self-efficacy with treatment adherence and self-management has been 
examined in several adolescent chronic illness samples, including asthma and insulin-dependent 
diabetes mellitus (IDDM). For example, Zebracki and Drotar (2004) investigated the relation 
among patient self-efficacy, treatment adherence, and self-management behaviors in a sample of 
77 adolescents with asthma (ages 11 to 17). Their results demonstrated that higher perceived self-
efficacy was associated with better self-reported adherence, but not self-management behaviors. 
Similarly, in a sample of adolescents with IDDM (ages 11 to 18), a positive relation was found 
between self-reported treatment adherence and self-efficacy (Ott, Greening, Palardy, Holderby, & 






levels of self-efficacy than younger adolescents, which indicates that youth may need to take 
responsibility for managing their disease slowly as their self-confidence in their own abilities 
increases.  
In addition to studies with other chronic illness samples, the association between self-
efficacy and treatment adherence has been explored in samples of adolescents with CF. 
Czajkowski and Koocher (1986; 1987) administered the Medical Compliance Incomplete Stories 
Test (M-CIST) to a sample of inpatients with CF aged 13 to 23 and gathered physician reports of 
compliance to chest physiotherapy, medications and vitamins, diet, and medical tests during the 
hospitalization. For the M-CIST, participants completed stories focusing on medical compliance 
issues and these stories were scored based on dimensions of compliance/coping, optimism, and 
self-efficacy. Czajkowski and Koocher’s results yielded a positive association between physician-
reported medical compliance and perceived self-efficacy. More specifically, patients who were 
more compliant with their treatment during hospitalization reported greater self-efficacy. However, 
the authors explained that patients usually demonstrate better compliance during inpatient 
hospitalization than when at home, so these findings may not generalize to the larger population of 
adolescents and young adults with CF. 
In a study evaluating the psychometric characteristics of a newly developed measure of 
self-efficacy, Bartholomew and colleagues’ (1993) investigated the relation between self-efficacy 
and CF self-management skills, such as monitoring for respiratory infections and ensuring 
adequate nutrition, among a sample of children and adolescents with CF (ages 7 to 18). Parents 
reported on the self-efficacy of children ages 7 to 12 using a parent version of the questionnaire, 






higher self-efficacy was associated with better self-management skills. In addition, Parcel and 
colleagues (1994) utilized an instrument to evaluate the self-efficacy of primary caregivers in 
managing their child’s disease with a sample of 199 children and adolescents with CF (ages less 
than 1 year to 18 years) and their primary caregivers. Their findings revealed that parents who 
reported higher self-efficacy also reported engaging in more care behaviors on behalf of their child 
than parents with lower self-efficacy. However, a high correlation between self-efficacy and self-
management would be expected for both studies because these variables were assessed via same 
methods (self- and parent-report).  
The results of the aforementioned studies suggest that self-efficacy is an important factor in 
the study of treatment adherence of adolescents with CF and may be considered a target of future 
interventions designed to increase adherence in this population. Nevertheless, much of the current 
research has relied on subjective measurement of treatment adherence (e.g., self-report), which 
may inflate the association with self-efficacy due to the shared method variance. In addition, the 
results of some studies may not generalize to all adolescents with CF because rates of adherence 
tend to be higher for inpatients than outpatients and these magnified rates may affect the relation 
with self-efficacy (e.g., Czajkowski & Koocher, 1986; 1987). Therefore, future research should 
include objective measures of treatment adherence and adolescents with CF from outpatient 
settings to examine the association of self-efficacy and adherence.  
Parental Style 
Due to the complexity of the CF treatment regimen, parents often must assist children and 
adolescents in completing treatment-related tasks, which may in turn place additional stress on the 






primary dimensions, control and warmth, and three different typologies: authoritarian, 
authoritative, and permissive (Baumrind, 1966). Currently, no studies have assessed parental style 
in adolescents with CF; however, some research has evaluated the association of other family and 
parenting factors with treatment adherence in youth with CF. In a study of 200 children and 
adolescents with Type 1 diabetes, asthma, or CF (ages 8 to 18), Bourdeau and colleagues (2007) 
found that parents who reported low levels of parenting stress had children and adolescents with 
higher ratings of self-care behaviors. Another study of youth with CF (ages 9 to 16) demonstrated 
an association between better treatment adherence and positive family relationships, but no relation 
between adherence and family problem-solving skills (DeLambo et al., 2004). Additionally, other 
studies indicated that greater family cohesion and flexibility were related to better self- and parent-
reported treatment adherence in children and adolescents with CF (Ricker et al., 1998; White, 
Miller, Smith, & McMahon, 2009). Overall, findings from previous studies suggest that family and 
parenting variables are associated with the treatment adherence of adolescents with CF.  
 Although parental style, per se, has not been examined in CF, the pediatric diabetes 
literature serves as an excellent example of why parental style is an important factor to consider in 
the prediction of treatment adherence. Using a sample of 55 children with Type 1 diabetes (ages 4 
to 10), Davis and colleagues (2001) demonstrated that children whose parents displayed warmth 
had better self-reported treatment adherence while parents who displayed a restrictive parental 
style had children with worse glycemic control (as assessed through glycosylated hemoglobin 
assays). However, parental restrictiveness was not associated with adherence and parental warmth 
was not associated with glycemic control. Moreover, Shorer and colleagues (2011) found worse 






reported having a higher sense of helplessness. Their results also demonstrated maternal 
permissive parenting style was associated with worse adherence, while paternal authoritative 
parenting style was associated with better adherence.  
Additionally, a few studies have investigated the associations among parenting and family 
factors, treatment adherence, and self-efficacy in children and adolescents with Type 1 diabetes. 
First, Armstrong, Mackey, and Streisand (2011) reported that children with Type 1 diabetes (ages 9 
to 11) who experienced more critical parenting behaviors regarding their treatment regimens 
displayed lower perceived self-efficacy than those who experienced less critical parenting 
behaviors. They explained that this finding highlights the detrimental effects of parental criticism 
on child adjustment, which may put children at risk for poor adherence. Next, a study of 11- to 17-
year-old adolescents with Type 1 diabetes found adolescents of mothers who demonstrated a style 
of firm control reported lower levels of self-efficacy (Bulter, Skinner, Gelfand, Berg, & Wiebe, 
2007). In contrast, adolescents of mothers whose parental style was characterized by acceptance 
reported higher levels of self-efficacy (Bulter, Skinner, Gelfand, Berg, & Wiebe, 2007). Finally, 
Berg and colleagues’ (2011) study demonstrated that self-efficacy mediated the association 
between paternal and maternal relationship quality and treatment adherence in a sample of children 
ages 10 to 14 with Type 1 diabetes. Furthermore, this relation was stronger for older children. Berg 
and colleagues concluded that early adolescents with high quality parental relationships might 
develop high levels of self-efficacy, which may prove beneficial as they begin managing their 
disease autonomously.  
 Previous research suggests that parenting and family variables are critical factors to 






toward having a more autonomous approach to disease management. Even though parental style 
has not been examined in youth with CF, studies with other chronic illness groups suggest that 
parental style is associated consistently with treatment adherence. Furthermore, the literature points 
to a relation between parenting and family variables and self-efficacy, which may have significant 
implications in the promotion of treatment adherence of adolescents with chronic medical 
conditions, including CF.  
Level of Responsibility  
As children with CF enter adolescence, they begin to assume greater levels of 
independence (Quittner et al., 2009). Therefore, it is important to assess the level of responsibility 
for CF care that is assumed by the adolescent in comparison to the level of responsibility assumed 
by the parent as this variable and conflicts related to it may result in reduced treatment adherence. 
Studies with other chronic illness samples, such as asthma and IDDM, have yielded mixed results. 
Ott and colleagues (2000) found that adolescents with IDDM who reported higher levels of 
responsibility demonstrated better adherence than those who reported lower levels of 
responsibility. Self-efficacy also was determined to mediate the relation between level of 
responsibility and adherence (Ott et al., 2000). Moreover, Walders and colleagues (2000) reported 
worse adherence for adolescents with asthma (ages 10 to 18) in families that overestimated their 
child’s level of responsibility for taking their medication. In another study of children and 
adolescents with asthma (ages 8 to 16), no association between level of responsibility and 
adherence was demonstrated (McQuaid, Kopel, Klein, & Fritz, 2003).  
Several studies investigating the level of responsibility for disease management also have 






colleagues (2007) completed qualitative interviews regarding family roles and responsibilities for 
managing chest physiotherapy (airway clearance) among children and adolescents with CF, aged 7 
to 17, and their parents. They determined that levels of child and parent responsibility for chest 
physiotherapy varied along a continuum from high parental/low child roles to low parental/high 
child roles, with lower levels of parental role associated with children’s increased autonomy in 
their disease management. Factors associated with family members’ level of responsibility were 
periods of wellness, periods of illness, and uncertainty regarding the child’s efficacy of performing 
the treatment. Results revealed the following perceived benefits of children assuming more 
responsibility for their care: a) child-reported benefits: greater flexibility in performing their 
treatment regimen, decreased feeling of burden on their family, and decreased parental surveillance 
for the children; b) parent-reported benefits: child’s greater level of responsibility and adherence, 
child’s increased autonomy, and less demands on the parents. Although this study provides some 
insight into the process of transferring disease management responsibilities from parents to 
children, it suggests a benefit of transferring responsibility is greater treatment adherence but does 
not directly measure this variable. Therefore, future research should examine whether an 
association exists between youth level of responsibility and treatment adherence. 
Other studies have established age ranges in which children begin to assume responsibility 
for their CF care. First, Drotar and Ievers (1994) explained that as children with CF and diabetes 
(ages 4 to 14) aged, their responsibilities for independently managing their illness and treatment 
increased. More specifically, children aged 11 to 14 with CF performed most of their treatment-
related tasks either independently or through sharing responsibility with their parents. Their results 






exhibited more responsibility in other domains, such as participating in activities away from home. 
However, parents continued to perform tasks that involved communicating with teachers or 
physicians, despite the child’s age. Second, Modi and colleagues (2008) stated that adolescents 
begin undertaking more responsibility for their treatment regimen and that parental supervision 
decreases at age 15. Moreover, results of their study of 103 preadolescents (ages 10 to 13.9) and 
adolescents (ages 14 to 17) with CF demonstrated that adolescents spend significantly more time 
completing disease management alone than preadolescents do. However, parents became more 
involved in disease management again between ages 16-17, which may be due to the adolescents’ 
poor treatment adherence. Taken together, these studies suggest children and adolescents begin 
taking responsibility for their care between 11 and 15 years of age, but parents continue to 
maintain some level of responsibility throughout adolescence. Given the variability of parental 
involvement and youth autonomy across disease-related tasks and ages in adolescence, additional 
research is necessary to understand the factors that are related to level of responsibility for CF care.  
In addition, there are mixed results regarding the association of treatment adherence and 
level of responsibility among children and adolescents with CF. Modi and colleagues (2008) 
determined that more supervision by mothers of children’s disease management activities was 
significantly associated with better adherence. They explained that adolescents (ages 14 to 17) may 
need more parental reminders for disease management while preadolescents (ages 10 to 13.9) may 
need more physical help with these activities. In contrast, Gudas and colleagues (1991) found no 
relation between level of responsibility and treatment adherence among children and adolescents 
with CF (ages 5 to 20). Based on these conflicting results, more research should be conducted to 






adherence in adolescents with CF, as well as factors that help to explain the relation between these 
variables. 
Summary of Relevant Literature and Rationale for Current Study 
CF is a genetic disease that disrupts the flow of water through the chloride channel and 
causes the body to secrete a sticky mucus (Colin & Wohl, 1994). The accumulation of mucus 
prevents proper functioning of many vital organs and individuals with CF experience many 
disease-related complications, such as pulmonary infections and pancreatic insufficiency 
(Strausbaugh & Davis, 2007). To maintain optimum health, individuals with CF must adhere to a 
complex daily treatment regimen, including airway clearance techniques, inhaled or oral 
antibiotics, pancreatic enzymes, and a high calorie and high fat diet (Quittner et al., 2009). 
However, patients often exhibit poor treatment adherence, which places them at risk for adverse 
health outcomes and can unnecessarily shorten their already shortened life span (Abbott & Gee, 
1998; Desmond et al., 1983). Therefore, treatment adherence is a major concern for individuals 
with CF. 
Treatment adherence rates among individuals with CF vary widely based on method of 
measurement, treatment regimen component, and age group examined. For example, Modi and 
colleagues (2006) found that children’s rates of adherence for pancreatic enzymes ranged from 
27% using daily phone diary data to 90% using child self-report data. Objective measures of 
adherence, such as phone diaries and pharmacy refill data, tend to produce significantly lower rates 
of adherence than self-report measures, which emphasize the importance of examining adherence 
through multiple methods (Modi et al., 2006). In addition, treatment adherence rates for 






groups of patients with CF and range from 57% to 70% depending on the component of treatment 
being measured (Zindani, Streetman, Streetman, & Nasr, 2006). Variation in adherence also exists 
because some regimen components able to be measured objectively (e.g., medication and airway 
clearance) while others are not (e.g., diet). Furthermore, due to advances in treatment, the many 
patients with CF are now living into adulthood and must transition to adult-oriented healthcare 
(Dugueperoux et al., 2008). Transition may put older adolescents at additional risk for poor 
adherence as a recent meta-analysis of adolescents with various chronic diseases revealed a 
significant reduction in adherence during transition (Pai & Ostendorf, 2011). This evidence 
suggests it is important to monitor treatment adherence and explore the factors related to adherence 
of adolescents with CF, especially those who are preparing for transition.   
Ultimately, poor rates of treatment adherence in adolescents with CF have generated 
interest in psychosocial factors that may promote adherence behaviors. First, adolescents with CF 
who reported higher self-efficacy also reported better treatment adherence and self-management 
skills than adolescents with lower self-efficacy (Bartholomew et al., 1993; Czajkowski & Koocher, 
1986; Czajkowski & Koocher, 1987). Moreover, several studies have demonstrated that lower 
levels of parenting stress, greater family cohesion and flexibility, and positive family relationships 
were significantly associated with better treatment adherence in adolescents with CF (e.g., 
Bourdeau et al., 2007; DeLambo et al., 2004; Ricker et al., 1998; White et al., 2009). However, the 
relation between parental style and treatment adherence has not yet been examined in CF. Because 
studies of other pediatric chronic illness groups indicate that parental style is associated with 
treatment adherence (Davis et al., 2001; Shorer et al., 2011), it is likely that this variable plays an 






children and adolescents with CF begin taking responsibility for their care between 11 and 15 years 
of age (Ievers & Drotar, 1994; Modi et al., 2008). In addition, there are mixed results regarding the 
association of treatment adherence and level of responsibility for disease management in youth 
with CF, with some studies suggesting more parental supervision is associated with better 
adherence (Modi et al., 2008) while other studies suggest no relation (Gudas et al., 1991). These 
conflicting results point to the need for more research to clarify the association between level of 
responsibility and treatment adherence in adolescents with CF. However, much of the literature is 
cross-sectional in nature and therefore, causal relations cannot be inferred. Future research utilizing 
longitudinal study designs may help to clarify the direction of these associations.  
Although studies have examined the associations of self-efficacy, parental style, and level 
of responsibility for disease management with treatment adherence separately, none have explored 
the interrelations of these variables in predicting adherence in adolescents with CF. However, 
studies of children and adolescents with other chronic medical conditions found associations 
between these variable to be meaningful, suggesting the need to investigate them in CF samples. 
For example, Berg and colleagues’ (2011) study demonstrated that self-efficacy mediated the 
relation between paternal and maternal relationship quality and treatment adherence in a sample of 
children with Type 1 diabetes. More specifically, high parental relationship quality (e.g., parent 
highly communicates love and acceptance of the child) was associated with high adolescent self-
efficacy and high self-efficacy was related to better treatment adherence. In addition, the majority 
of current research on factors associated with treatment adherence has utilized subjective measures 
of adherence, which may lead to biased results, and suggests the need for future research with 






Taken together, the results of the aforementioned studies suggest that self-efficacy, parental 
style, and level of responsibility for CF care may be important factors in the prediction of the 
treatment adherence of adolescents with CF and may be considered targets of future interventions 
designed to increase adherence in this population, particularly as they progress toward transition to 
adult healthcare. Therefore, the purpose of this study was to examine the role of self-efficacy, 
parental style, and level of responsibility for CF care, and the interrelations amongst these factors 
in predicting treatment adherence in adolescents with CF. More specifically, the specific aims and 
hypotheses of the current study were as follows:  
Aim 1: To determine whether parental style (parental care and protectiveness) moderated the 
relation between youth self-efficacy and treatment adherence. Based on previous research finding 
of warmth (Davis et al., 2001) and authoritative parenting style (Shorer et al., 2011) being 
associated with better adherence in pediatric diabetes, the following hypotheses were proposed:  
• Hypothesis 1a: Youth who report greater self-efficacy and have caregivers with higher 
parental care will have better adherence than youth who report greater self-efficacy and 
have caregivers with lower parental care. 
• Hypothesis 1b: Youth who report greater self-efficacy and have caregivers with lower 
parental protectiveness will have better adherence than youth who report lower self-
efficacy and have caregivers with lower of parental protectiveness.  
• Hypothesis 1c: Adherence will be the same (i.e., at a high level) when youth report either 






Aim 2: To determine whether youth level of responsibility for CF care mediated the relation 
between youth self-efficacy and youth treatment adherence. Based on Ott and colleagues’ (2000) 
findings that higher levels of youth responsibility were associated with better adherence in 
adolescents with IDDM, it was hypothesized that greater youth level of responsibility for CF care 





The sample included 60 patients with CF and their primary caregiver. One participant was 
excluded from all analyses due to lack of prescribed pulmonary medications (see Table 1 for 
sample demographics). This study included children and adolescents who: a) were between ages 
11 and 20; b) had a diagnosis of CF for at least one year prior to recruitment (to have sufficient 
time to develop adherence to the treatment regimen); and c) had a primary caregiver who was 
willing to participate with the adolescent. Patients who had a cognitive impairment that prevented 
them from completing the study questionnaires or who had already transferred their healthcare 
from pediatric to adult care were excluded from this study. The mean age of patients was 15.12 
years (SD = 2.77) and 55.9% of the patients were male. Primary caregivers who participated were 
primarily mothers (72.9%). In terms of lung functioning (FEV1), participants were, on average, at 
low risk for disease severity. However, participants’ average health status based on their body mass 
index (BMI) or BMI percentile was moderate risk.  
Participants were recruited from three pediatric CF centers across the United States (West 
Virginia University’s Mountain State CF Center, Children’s Mercy Hospitals and Clinics’ CF 
Center, and Boston Children’s Hospital CF Center). The breakdown of participants by recruitment 
site was as follows: 24 (40.7%) patients from West Virginia, 19 (32.2%) from Kansas City, and 16 
(27.1%) from Boston. Most patients were recruited during clinic appointments (n = 53, 89.8%); 
however, several also were recruited during hospitalization (n = 6, 10.2%).  
Procedure 
Prior to participant recruitment and data collection, the Institutional Review Boards at each 






they were interested in hearing about a research study. After participants agreed to hear about the 
study, research assistants described the study’s purpose and procedures as well as potential risks 
and benefits of participation in a private clinic or hospital room. Research assistants also discussed 
confidentiality and HIPPA guidelines with the participants. If participants agreed to the study, the 
research assistants obtained informed consent from the patient’s primary caregiver and patients 
aged 18-20. Patients aged 11-17 provided assent. In addition, patients or their parents (if patients 
are ages 11-17) completed the Authorization for Use and Disclosure of Personal Health 
Information Form so that research assistants could contact the patient’s pharmacy and obtain 
medication refill information.  
Each participant then completed a packet of questionnaires with reading assistance 
provided by the research assistants, if necessary. Caregivers and patients were instructed to fill out 
their forms independently but could pose questions to the research assistants if some parts of the 
questionnaires were unclear. The caregivers completed the Family Information Form (was 
completed with patient, when appropriate) and the Family Responsibility for CF Care – parent 
version. The patients completed the following questionnaires: a) Chronic Disease Self-efficacy 
Scales; b) Family Responsibility for CF Care – adolescent version; and c) Parental Bonding 
Instrument. Either the caregiver or patient completed the Pharmacy Information Form, depending 
on which family member assumed primary responsibility for refilling the patient’s medications. 
The length of time required to obtain informed consent and complete the questionnaires was 
approximately 60 minutes. Once the study packets were completed, research assistants briefly 
checked the forms to make sure that all pages and questions had been filled in correctly and 






questionnaire completion, research assistants left the room and returned to complete the study 
procedures after the physician examination was complete.  
In addition to the questionnaire packets, the patient’s physician or the CF center nurse 
manager completed the Prescribed Treatment Plan – CF and Medical Information Form while 
reviewing the patient’s medical chart. A research assistant also faxed or mailed a cover letter 
explaining the study and a copy of the participant’s Authorization for Use and Disclosure of 
Personal Health Information Form to each pharmacy listed on the participant’s Pharmacy 
Information Form to obtain pertinent medication refill data. Phone numbers of participating 
families were collected on the consent forms in case there were difficulties contacting the 
pharmacies for medication refill information. Patients received a $20 gift card and caregivers 
received a $10 gift card as remuneration for completing the study.   
Measures 
Chronic Disease Self-Efficacy Scales (Lorig, Stewart, Ritter, González, Laurent, & Lynch, 
1996). The Chronic Disease Self-efficacy Scales was used to measure adolescents’ confidence in 
managing their CF. This measure yields eight scales with multiple items (exercise regularly; obtain 
help from family, friends, and community; communicate with physician; manage disease in 
general; do chores; do social/recreational activities; manage symptoms; manage/control 
depression) and two one-item scales (get information on disease; manage shortness of breath). 
Items were rated on a 10-point Likert-type scale regarding confidence in one’s abilities from 1 = 
not at all confident to 10 = totally confident. To score each scale, the average of the items for that 






For this study, the following scales were utilized: a) communicate with physician; b) 
manage disease in general; c) manage symptoms; and d) manage shortness of breath. Internal 
consistency for the scales used in this study ranged from .87 (manage disease in general scale) to 
.91 (manage symptoms scale) (Lorig et al., 1996). Test-retest reliability for the aforementioned 
scales ranged from .82 (manage shortness of breath item) to .89 (manage symptoms scale) (Lorig 
et al., 1996). The Chronic Disease Self-efficacy Scales have been utilized to assess self-efficacy in 
samples of adults with heart disease, lung disease, and Type 2 diabetes (Lorig, Ritter, Laurent, & 
Plant, 2006; Lorig et al., 2010) and more recently, with a sample of adolescent and young adult 
survivors of childhood cancer (Taylor, Absolom, Snowden, & Eiser, 2011). For the current sample, 
internal consistency of this questionnaire was high (α = 0.95). 
Family Responsibility for CF Care (Johnson, Adams, Scotten, & Robinson, 2006). Patient 
and caregiver levels of responsibility for CF disease management was assessed with the adolescent 
and parent versions of the Family Responsibility for CF Care questionnaire. Each version of the 
Family Responsibility for CF Care has 17 items that describe different CF-related treatment tasks, 
three of which are completed only if the patient has CF-related diabetes. Adolescents and parents 
rated each item on a 5-point Likert-type scale regarding how responsibility was shared for CF-
related tasks over the past month (1 = parent is responsible all of the time, 2 = parent is 
responsible most of the time, 3 = share responsibility equally, 4 = child is responsible most of the 
time, 5 = child is responsible all of the time). After rating level of responsibility for each item, 
adolescents reported whether they would like more responsibility, less responsibility, or no change 
in responsibility. Similarly, caregivers reported whether they want the adolescent to have more 






indicated if an item did not apply to the patient’s care or if they chose not to do one of the tasks 
that a physician prescribed.  
To score the instrument, the average rating of level of responsibility of the items endorsed 
is calculated. Lower scores indicate higher parental responsibility for treatment tasks, while higher 
scores indicate higher adolescent responsibility. In addition, the percentage of items in which the 
participant believed that the patient’s responsibility should increase and the percentage of items in 
which the participant believed responsibility should decrease can be calculated. For the current 
study, only the average rating of level of responsibility was utilized in the analyses. Based on pilot 
data for 23 participants, both parent and youth versions demonstrated high internal consistency for 
all items, except the diabetes-related items as no participants completed them (parent version: α = 
0.94; youth version: α = 0.98) (Johnson et al., 2006). Other psychometric characteristics of the 
Family Responsibility for CF Care questionnaire are not yet available, as this is a newly developed 
scale that needs further study. It is noteworthy that there currently are no other questionnaires 
available to assess the division of responsibility for CF care within families. Internal consistency 
for the current sample was high for both versions (parent version: α = 0.98; youth version: α = 
0.97).  
Parental Bonding Instrument (PBI; Parker, Tupling & Brown, 1979). The PBI is a 25-
item self-report questionnaire that assesses the patient’s perception of his or her primary 
caregiver’s parental style during the first 16 years of his or her life. Items regarding parental 
behaviors and attitudes were rated on a 4-point Likert-type scale (very like to very unlike). This 
measure yields two scales: a) care scale (12 items); and b) protectiveness scale (13 items). Nearly 






while higher scores indicated warmth and empathy. Low scores on the protectiveness scale 
indicate encouragement of autonomy, while higher scores indicate prevention of autonomy and 
excessive control. Therefore, high scores on the protectiveness scale suggest a negative rating as 
patients who have rated caregivers in this way feel as though their caregivers overly restricted their 
independence during childhood.  
In addition, parents can be categorized into one of four different parental styles based on 
cutoff scores: a) affectionless control (low care and high protectiveness); b) affectionate constraint 
(high care and high protectiveness); c) neglectful parenting (low care and low protectiveness); and 
d) optimal parenting (high care and low protectiveness). The PBI has evidenced high internal 
consistency, as assessed through the split-half method, and high validity based on significant 
correlations with interview ratings of care and overprotection (Parker et al., 1979). This scale has 
also been utilized in samples of adolescents with Type 1 diabetes (Graue, Wentzel-Larsen, 
Hanestad, & Søvik, 2005) and youth with recurrent abdominal pain (Weydert, Shapiro, Acra, 
Monheim, Chambers, & Ball, 2006). For this study, only the care scale and protectiveness scale 
scores were utilized. Cronbach’s alpha coefficient for the current sample were as follows care scale 
= 0.90 and protectiveness scale = 0.84. The parental care scale is hereafter referred to as the 
parental warmth scale to reduce confusion between this scale and self-management/care behaviors 
that are part of the CF treatment regimen.  
Family Information Form. The Family Information Form was created for this study to 
collect data on demographic and medical information about the patient and primary caregiver, such 






Medical Information Form. The Medical Information Form was created for this study to 
collect medical data from reviewing the patient’s chart, such as number of attended clinic 
appointments in the past 12 months, number of hospital admissions in the past 12 months, 
measures of lung functioning (e.g., FEV1), and body mass index (BMI) and its age- and gender-
based percentile. 
Prescribed Treatment Plan – CF (Modi & Quittner, 2006; Quittner, Espelage, Ievers-
Landis, & Drotar, 2000). The patient’s physician completed the Prescribed Treatment Plan – CF, 
which collects information on the type, dosage, duration, and frequency of prescribed medications 
and other components of the patient’s treatment.  
Pharmacy Information Form. Either the primary caregiver or patient completed the 
Pharmacy Information Form to provide pharmacy names, addresses, phone numbers, and fax 
numbers for pharmacies that patients used in the past 18 months to refill prescriptions for all CF-
related medications. However, only medications for pulmonary care that have received an A/B 
recommendation (i.e., Pulmonary Clinical Practice Guidelines Committee recommends or strongly 
recommends routinely providing this medication; high certainty of substantial or moderate benefit) 
in the CF chronic medications guidelines (i.e., pulmozyme/dornase alpha, inhaled tobramycin, 
hypertonic saline, colistin, aztreonam lysine/cayston, and Zithromax/azithromycin) were utilized 
for the current study analyses (Mogayzel et al., 2013). The use of this specific combination of 
medications to calculate adherence rates has been previously examined in samples of youth with 
CF (Eakin, Bilderback, Boyle, Mogayzel, & Riekert, 2011). 
Pharmacy refill data were utilized as objective, proxy measures of treatment adherence. 






patient’s typical adherence to their treatment regimen. However, only 15 months of data were 
included in the analyses; the first three months of data collected were excluded from analyses to 
reduce inaccurate adherence estimates if participants had refilled a medication just prior to the 
beginning of the reporting period. Participants’ adherence to their medication regimens was 
determining by calculating a Medication Possession Ratio (MPR). The following MPR formula 
was utilized based on previous research with pediatric CF samples (Eakin et al., 2011): 
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All statistical analyses were conducted through use of Predictive Analytics Software and 
Solutions version 21 (SPSS 21). 
Power Analysis 
Using the aim with the largest number of predictors (Aim 1), a power analysis using G 
Power was conducted to approximate the study’s sample size. To detect a medium effect size with 
80% power and an alpha of .05, a sample of 77 participants is needed. To detect a large effect size 
with the same power and alpha, 36 participants are needed. Using the communication with 
physician, manage disease in general, and manage symptoms scales of the Chronic Disease Self-
efficacy Scales, Taylor and colleagues (2012) found medium and large effect sizes for prediction of 
adolescent and young adult cancer survivors’ self-efficacy by late effects (β = -0.22, R2 = 0.115, p 
= .004) and post-traumatic stress symptoms (β = -0.47, R2 = 0.292, p < .001). DeLambo and 
colleagues’ (2004) found a medium effect size for the prediction of parent-reported adherence to 
airway clearance/aerosols of youth with CF by parent-child relationship quality (β = 0.19, R2 = 
0.149, p < .05). Using parental supervision of treatment as predictors of adherence of adolescents 
with CF, Modi and colleagues (2008) found medium to large effect sizes for adherence to 
frequency of nebulized treatments (β = 0.38, adjusted R2 = 0.20, p < .05) and adherence to duration 
of nebulized treatments (β = 0.63, adjusted R2 = 0.31, p < .001). Although the aforementioned 
studies utilized different measures of treatment adherence, different measures of predictor variables 
(e.g., relationship quality versus parental style; parental supervision of treatment versus level of 
responsibility for disease management), and in one study, a different chronic illness sample, it is 
assumed that effect sizes in this study will be comparable. Therefore, this study aimed to recruit 







First, all data were reviewed to locate any missing data and to ensure that all missing data 
were random. Review of data revealed minimal amounts of missingness across study variables. 
Two participants were missing data from the entire Family Responsibility for CF Care – youth 
report and one participant was missing data from the entire Family Responsibility for CF Care – 
parent report. These participants were excluded for relevant analyses in aim 2. Person-mean 
imputation (i.e., substituting the participant’s mean score of completed items on a scale for the 
items that were not completed) was utilized to address missingness for other participants (all who 
had less than 10% missing data).  
Next, study variables were examined for skewness, kurtosis, and univariate outliers. These 
analyses revealed no outliers and two negatively skewed and kurtoic variables (Chronic Disease 
Self-efficacy Scales and Parental Bonding Instrument – warmth scale). To attempt to correct these 
issues, squareroot, log, and inverse transformations were performed. However, none of these 
transformations corrected the skewness or kurtosis of self-efficacy and parental warmth and 
therefore, the variables were retained in its original form. Descriptive statistics for all primary 
study variables are presented in Table 2.  
Examination of study variables by site revealed no significant differences, except with the 
Parental Bonding Instrument. Youth recruited from the Boston center (M = 6.25, SD = 4.54) 
reported significantly lower levels of parental protection than youth recruited from the West 
Virginia (M = 12.99, SD = 6.69) or Kansas City centers (M = 14.48, SD = 7.99). Additionally, 






levels of parental warmth than youth recruited from the West Virginia (M = 30.67, SD = 4.32) or 
Boston centers (M = 31.35, SD = 3.60).  
  Finally, Pearson and Spearman correlations were conducted with demographic and 
medical variables (e.g., patient age, number of clinic appointments attended), and the dependent 
variable (i.e., treatment adherence) to determine if any potential covariates need to be controlled 
for in the primary analyses. These correlations revealed a significant association between mother’s 
level of education and adherence, such that lower levels of maternal education were related to 
better adherence (r = - 0.32, p = 0.01). Due to its significant association with treatment adherence, 
maternal level of education was controlled for in the first step of all subsequent analyses. However, 
because two participants were missing data for maternal level of education, they were excluded 
from all subsequent analyses.  
Aim 1  
The first aim was to determine if there is a moderation effect for treatment adherence. First, 
the predictor (youth self-efficacy) and the moderator (parental warmth or protectiveness) were 
centered as both variables utilize a continuous scale. Next, the centered predictor and centered 
moderator were multiplied to create a product term to denote the interaction between the two 
variables. Three hierarchical multiple regressions were conducted with treatment adherence as the 
dependent variable. For each regression, the centered predictor (youth self-efficacy) and moderator 
(parental warmth or protectiveness) variables were entered in Block 1 and the product term 
(interaction between youth self-efficacy and parental warmth or protectiveness) was entered in 






Results of the first hierarchical regression revealed no significant moderation effect for the 
PBI – warmth scale on the association between self-efficacy and treatment adherence (see Table 
3). Similarly, the PBI – protectiiveness scale did not demonstrate a moderator effect on the 
association between self-efficacy and treatment adherence (see Table 4). For both moderation 
analyses, the only significant association was between maternal level of education and treatment 
adherence (β = - 0.26, p = 0.05).  
Aim 2 
The second aim was to determine if there is a mediation effect for treatment adherence. 
Using Baron and Kenny’s approach (1986) for testing mediation, three simultaneous, multiple 
regressions were calculated for treatment adherence. The first regression examined the relation 
between the predictor (youth self-efficacy) and the hypothesized mediator (youth level of 
responsibility for CF care). The second regression examined the relation between the predictor 
(youth self-efficacy) and the dependent variable (treatment adherence). The third regression 
examined the relation among the predictor (youth self-efficacy) and hypothesized mediator (youth 
level of responsibility for CF care), and the dependent variable (treatment adherence).  
Due to missingness, the first mediation model had a sample size of 55 (Family 
Responsibility for CF Care – youth report). Step 1 of model revealed no significant association 
between self-efficacy and treatment adherence (β = -0.05, p = 0.74). Step 2 demonstrated a 
significant association between self-efficacy and youth-reported level of responsibility, such that 
youth who reported being more self-efficacious also reported taking on more responsibility for 






responsibility did not significantly mediate the association between self-efficacy and treatment 
adherence (β = 0.16, p = 0.29). 
 Due to missingness, the second mediation model had a sample size of 56 (Family 
Responsibility for CF Care – parent report). Similar to the first mediation model, no significant 
association between self-efficacy and treatment adherence was found for the second mediation 
model (β = - 0.04, p = 0.77). Step 2 revealed a significant association between self-efficacy and 
parent-reported level of responsibility, such that youth who reported being more self-efficacious 
were reported by their parents to take on more responsibility for their disease management (β = 
0.31, p = 0.02). Lastly, parent-reported level of responsibility did not have a significant mediator 




The aims of the current study were twofold: 1) determine whether parental warmth and 
protectiveness moderated the relation between youth self-efficacy and treatment adherence; and 2) 
determine whether youth level of responsibility for CF care mediates the relation between youth 
self-efficacy and youth treatment adherence. Contrary to hypotheses, neither parental warmth nor 
protectiveness moderated the association between youth self-efficacy and treatment adherence. In 
addition, neither youth- nor parent-reported division of responsibility for disease management 
mediated the association between self-efficacy and treatment adherence. In fact, self-efficacy was 
not significantly associated with treatment adherence. However, greater youth self-efficacy was 
significantly associated with youth taking on more responsibility for their disease management. 
Overall, the study results did not support the proposed hypotheses.  
While previous research has demonstrated a significant relation between self-efficacy and 
treatment adherence in youth with CF (Bartholomew et al., 1993; Czajkowski & Koocher, 1986; 
Czajkowski & Koocher, 1987), this study’s findings did not support this association. One possible 
explanation for this may be method of assessing adherence. Prior research has primarily utilized 
subjective measures of treatment adherence, such as self-report questionnaires (Bartholomew et al., 
1993; Czajkowski & Koocher, 1986; Czajkowski & Koocher, 1987), while this study utilized a 
more objective measure of adherence (i.e., pharmacy refill data). It is possible that previous studies 
demonstrated an association between self-efficacy and adherence due to shared method variance, 
which was not present in the current study.  
Another possible explanation for the conflicting results is that the current study’s sample 
primarily included outpatients rather than inpatients, with the latter primarily comprising the 






inpatients tend to be higher than among outpatients, it may be that self-efficacy is only an 
important factor in patients who demonstrate high rates of adherence. For those with low rates of 
adherence, confidence in one’s abilities to manage their disease may have less association with 
adherence than other barriers, such as time management and forgetfulness (Modi & Quittner, 
2006). It is possible that relative to self-efficacy, the aforementioned barriers impacted the current 
sample’s adherence rates more significantly. Indeed, mean adherence for this study’s participants 
was 20.2%, which is considerably lower than rates (median Composite MPR = 63%) reported in a 
previous study using pharmacy refill data (Eakin et al., 2011). However, Eakin and colleagues’ 
study utilized a much larger age range (age 6 to 35+) than the current study (ages 11 to 20). This 
study focused on adolescence, when adherence is notoriously the poorest among patients with CF, 
and therefore, it is logical that adherence is much lower in the current study. This study’s mean 
adherence also was much lower than previous studies focusing on outpatient adolescents with CF 
(Ziadini et al., 2006). However, Ziadini and colleagues utilized electronic monitoring to assess 
adherence so differences in measurement technique may account for differences in mean 
adherence rates.  
Lastly, previous studies have utilized CF-specific self-efficacy measures while the current 
study utilized a general disease self-efficacy measure that had not been validated with CF samples. 
The general disease self-efficacy measure may have failed to capture important aspects of self-
efficacy for individuals with CF, which may be more relevant to their adherence. However, the 
general disease self-efficacy measure was chosen for the current study due to a lack of 
psychometric data on the only available CF-specific measure and being unable to obtain the 






The lack of relation between parental style and treatment adherence was surprising given 
previous literature with other pediatric chronic illnesses (Davis et al., 2001; Shorer et al., 2011). 
However, given that earlier research in CF has found associations only between adherence and 
other family/parenting variables (Bourdeau et al., 2007; DeLambo et al., 2004; Ricker et al., 1998), 
it may be that parental style is not as important a factor for youth with CF as other family/parent 
variables (e.g., family cohesion). For example, Bourdeau and colleagues examined the relation 
between parental overprotection and adherence in a sample of youth with type 1 diabetes, asthma, 
and CF, but found no significant associations among these variables in any disease group. It is 
possible that the family/parenting variables that have previously demonstrated associations with 
treatment adherence are more pertinent than parental style in how well a patient follows their 
treatment regimen. For example, parent-child interactions surrounding disease management tasks 
may not only be more relevant to treatment adherence, but also may be more objectively assessed 
through behavioral observations and demonstrate a clearer relation with adherence. Finally, the 
PBI may not be the best measure of parental style as it asks youth to recall their parents’ behavior 
over the first 16 years of the patient’s life and the patients may be inaccurately rating their parents’ 
style due to recall biases. Utilizing a measure of parental style with a shorter recall time frame may 
lead to different results regarding the association of parental style and adherence.  
Level of responsibility for disease management also did not demonstrate a significant 
association with treatment adherence. Previous literature examining this association has been 
mixed with some studies suggesting an association exists (Modi et al., 2008) and some studies 
suggesting no association (Gudas et al., 1991). The addition of this study’s results to the current 






adherence among youth with CF. Similar to studies examining self-efficacy, many studies that 
demonstrated significant associations between level of responsibility and treatment adherence 
among other pediatric illness groups utilized subjective adherence measures (Ott et al., 2000; 
Walders et al., 2000). Therefore, it is possible these previously demonstrated associations might be 
accounted for by shared method variance. 
Although this study’s hypotheses were not supported by the results, one interesting finding 
emerged: youth who reported higher levels of self-efficacy also reported taking on greater 
responsibility for their disease management. This finding is consistent with Ott and colleagues’ 
(2000) finding that self-efficacy was significantly related to level of responsibility in youth with 
IDDM. It may be that youth’s confidence in their abilities to manage their disease is associated 
with them independently performing self-management tasks (e.g., taking medication, calling their 
physician when ill), but that this autonomy does not translate into regimen adherence. On the other 
hand, it is possible that youth who take on more responsibility for their disease management 
develop greater self-efficacy due to that increased responsibility. Nevertheless, it may be important 
to promote self-efficacy during adolescence in order to increase youth independence in their 
disease management and prepare them for the transition from pediatric to adult healthcare. Making 
decisions about disease management and being responsible for completing treatments are 
important skills for successful transition (Westwood et al., 1999). Moreover, it is possible that 
adolescents who lack appropriate skills to care independently for their disease may be at risk for 
poor health outcomes later in life. Therefore, it is essential that youth begin taking on responsibility 
for disease management tasks during adolescence when they have parental supervision to ensure 






and youth responsibility, interventions aimed at increasing youth confidence in their disease 
management abilities may in turn increase their level of responsibility. Such interventions may 
include parental modeling of tasks for the adolescent, scaffolding with the adolescent to increase 
their accuracy in task performance, and praising the adolescents for independently and accurately 
completing disease management tasks.  
In addition, an unexpected relation between maternal level of education and treatment 
adherence was demonstrated, such that lower levels of maternal education were associated with 
better adherence. This finding is inconsistent with previous literature in CF that has either 
demonstrated a positive association between maternal education and adherence (Gudas et al., 
1991) or no significant association between these variables (Bourdeau et al., 2007; Delambo et al., 
2004; Modi et al., 2008; Ricker et al., 1998; White et al., 2007). Given that the majority of 
previous research revealed no significant association between maternal education and adherence, it 
is possible the negative correlation found in the current study is due to type I error. On the other 
hand, there may be other variables, such as trust and beliefs about decision-making ability, which 
underlie the relation between high level of education and low adherence. For example, literature 
reviews on treatment adherence to medications in adults with heart-related issues (e.g., 
hypertension, high cholesterol) revealed findings similar to the current study (Jin, Sklar, Oh, & Li, 
2008; Kneeland & Fang, 2010). These authors explained that individuals with higher levels of 
education may be more likely to be non-adherent due to inflated self-confidence in decision 
making capabilities and distrust of medical providers. Thus, some of these same variables may 
play a role in the adherence of youth with CF who have highly educated mothers. However, 






treatment adherence in pediatric CF and to determine whether the aforementioned factors mediate 
this relation. 
Despite the current study’s strengths, there are a few limitations worth noting. First, all data 
collected are cross-sectional in nature and thus, causality of associations cannot be inferred. Future 
research that utilizes longitudinal methods is warranted to determine the direction of associations 
among variables. Additionally, all the measures utilized in this study focused on different time 
frames (e.g., PBI assessed parental style across 16 years of the patient’s life whereas the Chronic 
Disease Self-Efficacy Scales assessed patient self-efficacy at the present time). Therefore, it is 
possible the lack of significant associations between study variables may be a function of the 
different time frames of the measures. For example, it may that parental style at the present time is 
associated with the youth’s current rate of treatment adherence, but this association was not 
captured by the current study given the different time frames. It also is possible the association 
between youth self-efficacy and family division of responsibility was evidenced due to 
measurement time frames as these measures both assessed the constructs at the present/current 
time.  
Moreover, though pharmacy refill data were chosen to index treatment adherence because 
they are more objective than questionnaire data, these data are not without their own limitations. 
Pharmacy refill data only provide an estimate of medication possession, not an assessment of 
medication ingestion; thus, it is possible that patients may be refilling their medications but not 
actually taking them (Choo et al., 1999; Eakin et al., 2011). In addition, pharmacy refill data may 
over-estimate adherence because families may stockpile medications (Choo et al., 1999; Eakin et 






aforementioned limitations suggest adherence ratings would be higher instead of lower than 
expected. In contrast, families not providing a comprehensive list of the pharmacies they use to fill 
the patient’s medications on the Pharmacy Information Form may explain this study’s low 
adherence rates. It is possible families simply listed the pharmacies they currently use rather than 
listing all pharmacies they have used during the pharmacy refill data collection time frame (i.e., the 
past 18 months). In addition, patient treatment plans and medications frequently change based on 
the patient’s health status; however, this study only used the patient’s most recent treatment plan to 
compare to the pharmacy refill data and thus, did not account for such changes in prescribed 
medications. Therefore, future research utilizing other objective measures of adherence (e.g., 
electronic monitoring) may reveal associations between variables not demonstrated in this study.  
Overall, the results of this study did not support the proposed hypotheses. No significant 
moderation effect for parental style or mediation effect for level of responsibility was found for 
self-efficacy and treatment adherence. Nevertheless, the current study had a number of 
methodological strengths. This was a multi-site study with a relatively large sample size compared 
to previous studies on treatment adherence in CF samples (N’s = 33-40; Czjkowski and Koocher, 
1986; 1987; Eakin et al., 2011; Ziadini et al., 2006). In addition, this study utilized a multi-method, 
multi-informant approach to assess study variables and therefore, was not subject to the limitation 
of results due to shared method variance. Treatment adherence is a complex behavior that includes 
many disease regimen tasks that were not assessed by the pulmonary composite MPR of the 
current study. For example, chest physiotherapy (e.g., vest, acapella) is an important component of 
the CF treatment adherence; however, this component is not a medication and therefore, adherence 
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Table 1  
Sample Demographics 
 
Variables (N = 59) n (%) Mean SD Range 
Patient age 
 
 15.12 2.77 11 – 20  
Patient gender 
    Male 





   
Patient race 
    White 
    Black 
    White/Black 







   
Hospital days in past 12 months 
 
 10.41 22.91 0 – 118  
Most recent BMI percentile rank for  
11 – 19 year olds (n = 56) 
 
 42.72 28.04 0.72 – 99  
Most recent BMI measurement for 20 
year olds (n = 3) 
 
 19.21 3.59 16.08 – 23.13 
Most recent FEV1 measurement 
 
 79.94 25.04 30 – 125  
Primary caregiver relationship 
    Mother 
    Father 
    Grandmother 







   
Primary caregiver age  
 
 44.56 7.91 30 – 65  
Family structure 
   Intact 
   Blended 






   
Mother highest education level 
   Some high school 
   Graduated from high school 
   Some college or specialized training 
   Bachelor’s degree 
   Master’s or doctoral degree 
















Father highest education level 
   Some high school 
   Graduated from high school 
   Some college or specialized training 
   Bachelor’s degree 
   Master’s or doctoral degree 









   
Total family income 
   Less than $10,000 
   $10,000 – 14, 999 
   $15,000 – 24,999 
   $25,000 – 34,999 
   $35,000 – 49,999 
   $50,000 – 74,999 
   $75,000 – 99,999 
   $100,000 – 149,999 





















Descriptives of study variables 
 
Variables   
(N = 59 except were noted) 
Mean SD Possible 
Range 
Site Differences  
Treatment Adherence1  
 
20.16 18.26 0 – 100 0.93, ns 
Self-efficacy2 
 
8.18 1.62 1 – 10 0.18, ns 
Level of Responsibility – youth 
report3, 4 
 
3.76 0.83 1 – 5 0.81, ns 
Level of Responsibility – parent 
report3, 5  
 
3.08 0.89 1 – 5 1.83, ns 
Parental style – warmth scale6 
 
29.07 7.00 0 – 36 5.11, p = 0.009 
 
Parental style – protection scale7  11.64 7.37 0 – 39 7.45, p = 0.001 
1Medication Possession Ratio (percentage) 
2Higher scores = higher self-efficacy 
3Higher scores = higher youth responsibility, lower scores = higher parent responsibility, 
score of 3 = equal parent and youth responsibility 
4n = 57 
5n = 58 
6Higher scores = parental warmth and empathy, lower scores = parental coldness and 
neglect 
7Higher scores = prevention of autonomy and excessive control, lower scores = 









Moderation with Treatment Adherence and Parental Bonding Instrument (PBI) – warmth 
scale 
 
N = 57 β t F(df) p Adj. R2 
 
Step 1 
   
4.06 (1, 55) 
         
0.05 
 
      0.05 
 






  0.05 
 
 
Step 2  
   





       
      Self-efficacy 
  




    
0.72 
 
    
      PBI – warmth  
    








   






      Self-efficacy X PBI – warmth  
 















Moderation with Treatment Adherence and Parental Bonding Instrument (PBI) – 
protection scale 
 
N = 57 β t F(df) p Adj. R2 
 
Step 1 
   
4.06 (1, 55) 
         
0.05 
 
      0.05 
 










Step 2  
   





       
      Self-efficacy 
    






    
      PBI – protection  
    








   






      Self-efficacy X PBI – protection 
 
   - 0.21 
 
- 1.45 
  
0.15 
 
 
 
